Taken together, their findings and ours suggest that BRD4 plays an important general role in regulating replication stress responses, and that the effect of BRD4 inhibitors alone on inducing DNA damage in cancer cells may depend on the basal level of oncogene-induced replication stress. The gene discussed is BRD4; the disease is cancer.